New research, by the Universities of Glasgow and Manchester, has revealed an ‘Achilles heel’ of Chronic Myeloid Leukaemia (CML) and found drugs to successfully target this weakness and eradicate the disease in mice.
Myeloma UK has awarded grant funding to research teams based at Manchester Royal Infirmary and at the National Institute for Health and Care Excellence (NICE) for two new studies in partnership with Myeloma UK.
CRUK Glasgow Centre Seminar by Prof Sean Grimmond, Chair of Medical Genomics. Friday June 13th, 3:30 pm, Robertson Trust Lecture Theatre, Beatson Institute for Cancer Research. Followed by drinks in the Wolfson Wohl Cancer Research Centre cafeteria.